Keyware, Nyrstar, Telegraaf, Vopak: Benelux Equity Preview

The following companies may have unusual price changes in Benelux markets. Stock symbols are in parentheses, and prices are from the previous close.

The AEX-Index (AEX) in Amsterdam declined 4.11, or 1.1 percent, to 362.14. Belgium’s Bel20 Index fell 9.41, or 0.4 percent, to 2,666.24. Luxembourg’s LuxX Index lost 0.2 percent to 1,460.07.

Dutch stocks:

Telegraaf Media Groep NV (TELEG) : The Dutch newspaper publisher may report full-year profit excluding some items of 52.9 million euros ($73.1 million), according to the average of four analyst estimates compiled by Bloomberg. Telegraaf rose 0.1 percent to 14.32 euros.

Royal Vopak NV (VPK NA): The world’s largest chemical and oil storage company may report full-year net income rose to 276.8 million euros, according to the average estimate of nine analysts surveyed by Bloomberg. Vopak retreated 0.9 percent to 34.78 euros.

Belgian stocks:

Keyware Technologies NV (KEYW) : The Belgian supplier of electronic payment terminals reported full-year net income of 446,000 euros and expects an outcome of takeover talks with an undisclosed number of industrial partners during the third quarter. Keyware climbed 2.3 percent to 1.77 euros.

Nyrstar (NYR) NV: Existing investors in the world’s largest producer of refined zinc have until 4 p.m. in Brussels to buy seven new shares at 7 euros apiece for every 10 they hold. Nyrstar lost 2.5 percent to 9.91 euros. The subscription rights (NYR3 BB) fell 8.6 percent to 2.01 euros.

ThromboGenics NV (THR) : The Belgian developer of the microplasmin retinal-disorder medicine said it plans to seek U.S. and European regulatory approval for the experimental drug in the second half of 2011. The company had 109.2 million euros of cash and short-term investments on Dec. 31. The shares dropped 0.8 percent to 20.69 euros.

To contact the reporters on this story: Maud van Gaal in Amsterdam at mvangaal@bloomberg.net; John Martens in Brussels at jmartens1@bloomberg.net

To contact the editors responsible for this story: Frank Connelly at fconnelly@bloomberg.net; Angela Cullen at acullen8@bloomberg.net

Bloomberg reserves the right to remove comments but is under no obligation to do so, or to explain individual moderation decisions.

Please enable JavaScript to view the comments powered by Disqus.